Abstract: A backpack and hood combination device for shielding a user's head includes a backpack and a hood. The backpack comprises a pair of shoulder straps that is configured to position over shoulders of a user to couple the backpack to the user. An upper limit of the backpack is positioned proximate to a base of a neck of the user and a rear of the backpack substantially abuts a back of the user. The hood is coupled to and positioned in a pouch that is coupled to the upper limit proximate to the rear of the backpack. The hood is selectively extensible from the pouch through a pouch opening that is positioned in the pouch. The hood is configured to cover a head of the user to protect the head of the user from windchill and moisture.

Abstract: A backpack and hood combination device for shielding a user's head includes a backpack and a hood. The backpack comprises a pair of shoulder straps that is configured to position over shoulders of a user to couple the backpack to the user. An upper limit of the backpack is positioned proximate to a base of a neck of the user and a rear of the backpack substantially abuts a back of the user. The hood is coupled to and positioned in a pouch that is coupled to the upper limit proximate to the rear of the backpack. The hood is selectively extensible from the pouch through a pouch opening that is positioned in the pouch. The hood is configured to cover a head of the user to protect the head of the user from windchill and moisture.

Abstract: The invention relates generally to the gene, and mutations thereto, that are responsible for the disease hereditary hemochromatosis (HH). More particularly, the invention relates to the identification, isolation, and cloning of the DNA sequence corresponding to the normal and mutant HH genes, as well as the characterization of their transcripts and gene products. The invention also related to methods and the like for screening for HH homozygotes and further relates to HH diagnosis, prenatal screening and diagnosis, and therapies of HH disease, including gene therapeutics, protein and antibody based therapeutics, and small molecule therapeutics.

Abstract: A fine structure map of the 1 megabase region surrounding the candidate HH gene is provided, along with 250 KB of DNA sequence and 8 loci corresponding to candidate genes within the 1 megabase region. These loci are useful as genetic markers for further mapping studies. Additionally, the eight cDNA sequences corresponding to those loci are useful, for example, for the isolation of other genes in putative gene families, and as probes for diagnostic assays. Additionally, the proteins encoded by those cDNAs are useful in the generation of antibodies for analysis of gene expression and in diagnostic assays, and in the purification of related proteins.